GenMont Biotech Inc

GenMont Biotech Inc

3164 · TW · Healthcare / Biotechnology

16.60TWD-0.40 (-2.35%)

Price History

Full chart

Market Stats

Previous Close17.00
Open17.00
Day Range16.50 – 17.00
52-Week Range15.35 – 19.75
Volume38.20K
Market Cap1.42B
P/E (TTM)20.63
Forward P/E46.95
EPS0.80
Dividend Yield4.83%
Beta0.06
50-Day Avg16.10
200-Day Avg17.15

About

GenMont Biotech Incorporation engages in the research and development, manufacture, and sale of various probiotic health products in Taiwan, Singapore, Mainland Chinese, and internationally. The company offers OEM and ODM services, including functional probiotic raw materials, capsules, powder, tablets, and liquid products. GenMont Biotech Incorporation was founded in 2000 and is based in Tainan City, Taiwan.

Company Details

  • SectorHealthcare
  • IndustryBiotechnology
  • CEOYujin Chen
  • Employees0
  • HeadquartersNo.8, Nanke 7th Road, Tainan City, Taiwan, 741, Taiwan
  • Websitehttps://www.genmont.com.tw

Leadership

  • Yujin ChenManager
  • Zhao Tang HuangAccounting Supervisor

Financials

Income Statement

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue27.69M96.68M113.39M170.94M253.15M298.72M352.85M514.58M286.21M226.82M308.94M564.52M534.72M540.78M380.65M406.53M346.24M325.19M427.93M368.55M318.01M385.37M401.23M
Growth (%)-+249.13%+17.27%+50.76%+48.09%+18.00%+18.12%+45.84%-44.38%-20.75%+36.20%+82.73%-5.28%+1.13%-29.61%+6.80%-14.83%-6.08%+31.59%-13.88%-13.71%+21.18%+4.11%
Cost of Revenue64.23M55.71M43.24M41.86M45.67M50.22M70.66M121.14M94.44M82.67M94.90M311.18M261.43M230.70M116.05M128.99M116.54M109.80M128.60M111.83M106.82M147.19M149.59M
Gross Profit-40.98M70.14M129.08M207.47M248.50M282.19M393.43M191.78M144.15M214.03M253.35M273.29M310.08M264.60M277.55M229.70M215.39M299.33M256.72M211.19M238.18M251.63M
Gross Margin-42.38%61.86%75.51%81.96%83.19%79.98%76.46%67.01%63.55%69.28%44.88%51.11%57.34%69.51%68.27%66.34%66.23%69.95%69.66%66.41%61.80%62.72%
Operating Expense-66.29M77.40M94.17M140.22M173.25M185.93M236.75M208.41M173.64M157.13M397.71M319.25M328.19M155.54M154.72M152.93M138.39M155.84M196.53M204.20M198.06M193.88M
Operating Income--25.31M-7.25M34.91M67.25M75.25M96.27M156.69M-16.63M-29.49M56.90M-144.36M-45.97M-18.11M109.06M122.82M76.77M77.00M143.49M60.18M6.99M40.12M57.75M
Operating Margin--26.18%-6.40%20.43%26.57%25.19%27.28%30.45%-5.81%-13.00%18.42%-25.57%-8.60%-3.35%28.65%30.21%22.17%23.68%33.53%16.33%2.20%10.41%14.39%
EBITDA--21.07M16.48M29.40M81.56M95.59M122.68M185.92M74.61M60.12M77.57M-248.11M48.72M69.92M148.79M143.92M98.07M98.58M161.29M117.43M93.92M140.03M124.57M
EBITDA Margin--21.79%14.53%17.20%32.22%32.00%34.77%36.13%26.07%26.51%25.11%-43.95%9.11%12.93%39.09%35.40%28.32%30.32%37.69%31.86%29.53%36.34%31.05%
Net Income--34.36M-8.23M10.87M57.41M51.31M86.23M147.54M38.16M28.43M30.89M-386.16M-98.03M-235.94M45.60M158.02M57.45M60.88M113.13M56.98M32.99M57.25M57.20M
Net Income Margin--35.54%-7.25%6.36%22.68%17.18%24.44%28.67%13.33%12.53%10.00%-68.40%-18.33%-43.63%11.98%38.87%16.59%18.72%26.44%15.46%10.37%14.86%14.26%
R&D21.55M27.74M20.10M22.28M24.74M21.73M31.36M60.65M42.51M35.37M26.80M29.07M26.54M28.86M29.17M27.72M27.11M26.30M25.52M59.41M46.86M45.27M45.34M
R&D as % of Total Revenue77.81%28.69%17.73%13.03%9.77%7.28%8.89%11.79%14.85%15.59%8.67%5.15%4.96%5.34%7.66%6.82%7.83%8.09%5.96%16.12%14.74%11.75%11.30%
Interest Expense00000023.00K07.61M7.64M22.96M10.09M0000776.00K806.00K766.00K755.00K973.00K3.72M3.92M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.01%0.00%2.66%3.37%7.43%1.79%0.00%0.00%0.00%0.00%0.22%0.25%0.18%0.20%0.31%0.96%0.98%

Balance Sheet

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets258.26M309.07M313.55M520.93M571.68M680.96M724.10M1.37B1.49B1.43B1.37B1.74B1.63B1.40B1.50B1.66B1.57B1.61B1.70B1.70B1.65B1.71B1.67B
Total Liabilities9.63M14.91M23.41M59.18M47.04M71.36M88.42M627.66M588.06M566.61M536.49M144.76M133.43M124.14M129.41M95.60M123.04M130.95M173.65M198.59M204.06M229.06M215.35M
Total Equity248.64M254.56M247.00M443.65M502.79M581.84M607.49M706.87M675.27M861.62M837.28M1.60B1.50B1.28B1.34B1.49B1.38B1.33B1.38B1.35B1.32B1.35B1.33B
Cash6.55M24.69M69.83M297.47M452.00K367.97M330.04M791.41M144.30M467.89M542.53M315.33M95.73M176.55M170.18M225.29M191.67M274.85M169.95M133.69M55.59M110.51M103.73M
Total Debt------1.67M3.19M485.77M493.26M432.56M15.91M3.61M1.39M1.36M187.00K32.65M34.33M32.73M34.55M58.31M118.61M110.31M
Net Debt-----452.00K--328.37M-788.22M341.47M25.37M-109.97M-299.42M-92.12M-175.15M-168.81M-225.10M-159.02M-240.52M-137.22M-99.14M2.71M8.10M6.58M

Cash Flow

Currency: TWD2003-12-312004-12-312005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow--9.53M29.56M43.36M100.62M108.53M200.03M39.94M-23.58M100.37M-62.00M-5.01M45.34M77.56M56.03M74.52M118.27M111.66M137.95M34.60M123.95M73.60M
Investing Cash Flow19.33M-32.13M42.02M--41.17M-80.40M-185.03M81.94M412.44M72.96M-115.16M-214.43M36.41M-123.18M-1.43M4.42M6.78M-153.07M-82.73M-75.37M-82.42M7.70M
Financing Cash Flow-40.34M520.00K156.06M1.73M26.05M-66.06M446.69M109.13M-65.06M-99.01M-50.34M-12.30M-455.00K33.32M2.29M-100.93M-49.33M-61.37M-91.08M-36.82M12.55M-88.64M
Capital Expenditure4.45M9.02M6.24M3.37M64.37M40.30M21.52M18.32M7.10M1.38M10.54M35.85M24.43M32.57M28.25M275.30M393.72M138.99M117.12M70.93M35.54M44.27M3.65M
Free Cash Flow-----60.32M87.01M181.72M32.84M-24.96M89.83M-97.85M-29.44M12.76M49.31M-219.26M-319.20M-20.71M-5.46M66.04M-941.00K79.67M69.94M
Dividends Paid-----28.76M53.31M53.31M130.12M65.06M30.46M---133.37M133.37M133.37M71.15M60.44M95.01M60.46M43.26M69.21M
FCF to OCF-----59.95%80.17%90.84%82.23%105.86%89.50%157.83%587.56%28.15%63.58%-391.32%-428.38%-17.51%-4.89%47.88%-2.72%64.28%95.04%
Dividend Paid to FCF-----47.68%61.28%29.34%396.23%-260.68%33.90%---270.46%-60.83%-41.78%-343.49%-1107.35%143.86%-6425.08%54.29%98.95%

Earnings

Report DateMar 31, 2008Jun 30, 2008Sep 30, 2008Dec 31, 2008Mar 31, 2009Sep 2, 2009Dec 2, 2009Mar 3, 2010Jun 2, 2010Sep 1, 2010Dec 1, 2010Mar 2, 2011Apr 21, 2011Aug 31, 2011Nov 30, 2011Feb 29, 2012May 30, 2012Aug 29, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Sep 3, 2014Dec 3, 2014Feb 25, 2015Jun 3, 2015Sep 2, 2015Dec 2, 2015Mar 2, 2016Jun 1, 2016Aug 12, 2016Nov 11, 2016Mar 30, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Mar 30, 2018May 30, 2018Aug 29, 2018Nov 28, 2018Mar 28, 2019May 29, 2019Aug 28, 2019Nov 27, 2019Mar 26, 2020Jun 3, 2020Sep 2, 2020Dec 2, 2020Jun 2, 2021Sep 1, 2021Dec 1, 2021Jun 1, 2022Aug 31, 2022Nov 30, 2022Mar 15, 2023May 31, 2023
EPS Estimate------------0.63----------------------------------------------
EPS Actual0.300.40-0.000.300.200.390.330.690.850.710.470.760.76-0.450.990.06-0.120.040.76-0.220.340.370.24-0.46-0.12-0.39-0.81-4.49-0.30-0.280.12-0.65-0.09-0.01-0.11-2.44-0.030.460.26-0.180.051.040.410.280.460.050.18-0.040.100.170.330.350.170.270.270.140.090.160.10
Surprise------------20.63%----------------------------------------------
Timing------------Pre-market--------------------Pre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market-------------------

Key Statistics & Ratios

Market Cap1.42B
Enterprise Value1.09B
Trailing P/E20.63
Forward P/E46.95
PEG Ratio0.00
Price / Sales3.71
Price / Book1.05
EPS0.80
Book Value15.23
Revenue (TTM)382.11M
Gross Profit (TTM)227.50M
EBITDA91.53M
Profit Margin18.10%
Operating Margin14.22%
Return on Equity4.26%
Return on Assets1.09%
Shares Outstanding86.01M
Shares Float55.72M
Beta0.06
Dividend Yield4.83%
Dividend Rate0.80
Payout Ratio100.00%

Dividends

20231×
0.70Jun 28, 2023
20221×
1.10Jun 24, 2022
20211×
0.57Aug 26, 2021
20201×
0.80Aug 5, 2020
20191×
1.50Jul 22, 2019
20131×
0.50Aug 6, 2013
20121×
0.99Aug 8, 2012
20111×
1.99Sep 2, 2011
20101×
0.99Jun 15, 2010
20091×
0.90Jul 16, 2009
20081×
0.54Apr 24, 2008

Stock Splits

  • Sep 4, 2014727:722
  • Jun 15, 201011:10
  • Dec 18, 2006906:1141
  • Nov 6, 20064557:4471
  • May 20, 2004757:752